FVTF inhibits hepatocellular carcinoma stem properties via targeting DNMT1/miR-34a-5p/FoxM1 axis
FVTF inhibits HCC cell stem properties by targeting DNMT1/miR-34a-5p/FoxM1 axis, which is associated with HCC recurrence and prognosis, and FVTF is a prospective treatment drug for human HCC.
Authors
- Yebei Qiu
- Xiaocheng Cao
- Jinwu Peng (ORCID: https://orcid.org/0000-0001-5369-6724)
- Hong Liang Yi (ORCID: https://orcid.org/0000-0002-2853-2848)
- Zhi‐Qiang Xiao (ORCID: https://orcid.org/0000-0002-5127-586X)
- Di Wu (ORCID: https://orcid.org/0009-0009-0405-8350)
- Zheng-Zheng Yu (ORCID: https://orcid.org/0000-0003-3693-2435)
- Hui Zou (ORCID: https://orcid.org/0000-0003-4798-9904)
- Wei Zhu (ORCID: https://orcid.org/0000-0001-6550-593X)
- Shan-Shan Lu
- Jianguo Cao (ORCID: https://orcid.org/0000-0002-9125-2195)
- Wei Huang (ORCID: https://orcid.org/0000-0001-8659-322X)
Institutions
- Central South University (CN)
- Hunan Normal University (CN)
- Hunan Cancer Hospital (CN)
- National Clinical Research (US)
- Xiangya Hospital Central South University (CN)
Publication Details
- Journal
- Chinese Medicine
- Published
- 2025-03-06
- DOI
- https://doi.org/10.1186/s13020-025-01084-3
- Citations
- 1
- Primary Topic
- FOXO transcription factor regulation
- Type
- article
- Field-Weighted Citation Impact
- 0.81
Funders
- National Natural Science Foundation of China